Pharmacy Report Archives - Page 12 of 153 - Becker's Hospital Review

Why tech, workforce drive pharmacy growth | FDA seeks more Lilly GLP-1 pill data + 5 moves to watch | 10 systems hiring pharmacy leaders | PBM exclusions top 600 drugs

Plus: Why health systems are flocking to Florida — and what it means for patients April 16, 2026 1. Why tech, workforce are key to Prisma outpatient pharmacy growth Full story 2. FDA seeks additional safety data for Lilly GLP-1…

House weighs counting drug costs toward deductibles | 5 GLP-1 updates | Mount Sinai's pharmacy unification strategy | 3 drugs to watch in FDA pipeline | Ind. hospital drug diversion deal rejected

Plus: White House floats new top pick for CDC director April 15, 2026 1. Inside Mount Sinai's push to unify pharmacy care Full story 2. House eyes bill to allow drug expenditures to count toward insurance deductibles Full story 3.…

What drives hospital pharmacy hiring? | 6 new drug shortages | A contender for FDA vaccine director | Mich. system to transfer pharmacy ownership | 100 vulnerable meds in US supply chain: Report

April 14, 2026 1. 6 new drugs in shortage Full story 2. Pharmacy leaders weigh experience, NAPLEX scores during hiring process Full story 3. Procurement inconsistency grows with expansion. Strategies to enforce control without losing flexibility here. 4. White House considers…

Oral GLP-1 hits retail: 3 notes for hospitals | How Mass. system manages drug shortages | CMS eyes drug prior auth expansion | GSK pulls drug app amid White House autism spotlight | AI may streamline EHR drug safety

Plus: N.C. system opens community pharmacy April 13, 2026 1. 216 active drug shortages: How 1 health system is managing Full story 2. Eli Lilly's oral GLP-1 now available at Amazon, GoodRx: 3 notes for hospitals Full story 3. Chief…

AbbVie sues HHS over 340B definition | UMiami Health taps CPO | 10 systems hiring pharmacy leaders | Safety concerns stall Geisinger pharmacy center | Pharma industry's top lobbyist to exit

Plus: High-dose Wegovy launches at $399 for self-paying patients April 9, 2026 1. AbbVie sues HHS over 340B patient definition Full story 2. U of Miami Health System names Baptist Health pharmacy leader as CPO Full story 3. Procurement inconsistency…

Top pharmacy schools: US News | FDA seeks sweeping policy shifts | Leaders debate GLP-1 promise | Judge allows mifepristone by mail | Novel hemophilia gene therapy debuts

Best pharmacy schools, FDA budget overhaul and GLP-1 oncology debate top today’s news April 8, 2026 1. 2026 best pharmacy schools: US News Full story 2. FDA seeks sweeping policy changes in budget proposal Full story 3. Find case studies…

Court vacates 340B hospital purchasing policy | 2 drugmakers join TrumpRx | FDA issues new compounded GLP-1 rules | DEA suspends Tenn. pharmacy | Ore. passes mobile pharmacy bill

340B policy vacated, TrumpRx expands and GLP-1 guidance top today’s news April 7, 2026 1. Court vacates 340B policy on hospital drug purchasing: 6 things to know Full story 2. 2 more drugmakers join TrumpRx Full story 3. What C-suite…

Why hospital pharmacy AI pilots stall | The case for protecting 340B | CDC flags new sedative in fentanyl supply | Trump imposes drug import tariff | 3.1M eye drops recalled

Pharmacy AI hurdles, 340B debate and 100% drug tariff top today’s news April 6, 2026 1. AI in pharmacy: Why pilots stall at hospitals Full story 2. System CEO: 340B is not a problem to be solved, but a promise…

12 pharmacy leaders on what's ahead | FDA OKs Lilly's GLP-1 weight loss pill | Court upholds block on W.Va. 340B law | 10 systems hiring pharmacy leaders | MD, PharmD rank highest for ROI

Lilly GLP-1 pill approval, 340B ruling and pharmacy outlook top today’s news April 2, 2026 1. Optimists, pessimists and realists — 12 pharmacy leaders on the future Full story 2. FDA approves Eli Lilly's GLP-1 pill for weight loss Full…

Pharmacy leaders outline top bets | Amgen drug under FDA scrutiny after deaths | Novartis challenges Wash. 340B law | 13 potential GLP-1 benefits | Flu shot label adds seizure warning

Amgen safety review, 340B legal battle and GLP-1 insights top today’s news April 1, 2026 1. The big bets 20 pharmacy leaders are making right now Full story 2. Amgen drug under FDA review in wake of 8 deaths Full…